NutraNomics (NNRX) Announces Participation in Utah Cann 2019
13 March 2019 - 6:23AM
InvestorsHub NewsWire
SALT LAKE CITY, UT -- March 12, 2019 -- InvestorsHub NewsWire
-- NutraNomics is proud to announce their participation as a
Platinum level sponsor at Utah Cann 2019 (www.utahcann.com), Utah’s
second annual Cannabis Business Conference and expo to be
held May 10th & 11th, 2019 in Salt Lake City,
Utah.
Utah Cann endeavors to provide educational resources on all
aspects of the cannabis industry, including scientific strides
regarding medical benefits, agricultural and cultivation
techniques, investment and business opportunities, and the rapidly
shifting political landscape.
Utah Cann, a locally developed conference, is held in Salt Lake
City - the hometown of NutraNomics. Following the passing of
Proposition 2 in December of last year (a bill legalizing medical
cannabis), Utah is now preparing for a medical cannabis program, to
be fully integrated by 2021. The people of Utah have voted and
established not only demand but a desire for a cannabis-based
industry in the state.
“As a nutraceutical and medical based company, NutraNomics is
excited to help drive the education and propagation of cannabis
education. Sharing what we have learned in regard to
innovative formulations in the hemp industry is the start of many
contributions we will be making to the state,” according to
Jonathan Bishop, CEO of NutraNomics. “We have been diligently
working to bring responsible agricultural practices together with
novel scientific approaches for the treatment of disease.
Seeds, Science, Solutions – that is our motto but also
where the science-based inquiries begin for most research. If we
are able to provide insight to not only the people but the decision
makers, we are happy to do so.”
Dr. Tracy Holford, Chief Scientist at Tempus Bio Technologies,
and Nutranomics science partner will also be presenting on a
scientific panel at the event. "Nano-sized materials have been
around since the Earth was formed. What is new is our
understanding of how beneficial nano-sized supplements are in
helping effectively deliver elements with traditionally limited
bioavailability," says Dr. Holford. "The term Nano and Nano sizing
has been hijacked by the marketers to sell products regardless of
reality. Tempus Bio Technologies, with our partner
NutraNomics, is striving to reclaim the term as an honest
description of a product with proof of size, ingredients, and
clinical efficacy as we strive to reformulate a series of
Nutranomics winning formulations utilizing this proven
strategy."
As a Platinum Sponsor, NutraNomics will be preparing keynote
presentations and participating in other conference opportunities.
NutraNomics’ goal is to not only educate the industry and the
general public on the information they have acquired over the last
year but to also maintain open discussions with patients who
require specific treatment plans. As a burgeoning industry, hemp
offers an unending opportunity to offer healthy, plant-based
solutions to treatment of disease. NutraNomics strives to lead the
industry in responsible application and integration of the untold
power of cannabidiol and its entourage elements in the treatment of
disease.
Safe Harbor Statement
This press release contains forward-looking statements that can
be identified by terminology such as "believes," "expects,"
"potential," "plans," "suggests," "may," "should," "could,"
"intends," or similar expressions. Many forward-looking statements
involve known and unknown risks, uncertainties and other factors
that may cause actual results to be materially different from any
future results or implied by such statements. These factors
include, but are not limited to, our ability to continue to enhance
our products and systems to address industry changes, our ability
to expand our customer base and retain existing customers, our
ability to effectively compete in our market segment, the lack of
public information on our company, our ability to raise sufficient
capital to fund our business, operations, our ability to continue
as a going concern, and a limited public market for our common
stock, among other risks. Many factors are difficult to predict
accurately and are generally beyond the company's control.
Forward-looking statements speak only as to the date they are made
and we do not undertake to update forward-looking statements to
reflect circumstances or events that occur after the date the
forward-looking statements are made.
Source: NutraNomics, Inc.
Jonathan Bishop
CEO
NutraNomics Inc.
www.NutraNomics.com
Nutranomics (CE) (USOTC:NNRX)
Historical Stock Chart
From Nov 2024 to Dec 2024
Nutranomics (CE) (USOTC:NNRX)
Historical Stock Chart
From Dec 2023 to Dec 2024